18 December 2015 in Australian Journal of Rural Health
6 July 2020 in British Journal of Dermatology
Background Discovering the genetic basis of inherited skin diseases is fundamental to improving diagnostic accuracy and genetic counselling. In the 1990s and 2000s, genetic linkage and candidate gene approaches led to the molecular characterisation of several dozen genodermatoses, but over the past decade the advent of next‐generation sequencing (NGS) technologies has accelerated diagnostic discovery and precision. Objectives This review examines the application of NGS technologies from 2009 to 2019 that have (a) led to the initial discovery of gene mutations in known or new genodermatoses and (b) identified more than one contributing pathogenic gene involvement in individuals with complex Mendelian skin disorder phenotypes. Methods A comprehensive review of the PubMed database and dermatology conference abstracts was undertaken between January 2009 to December 2019, collated and cross‐referenced with OMIM. Results We identified 166 new disease‐gene associations in inherited skin diseases discovered by NGS. Of these, 131 were previously recognised, while 35 were brand new disorders. Eighty‐five were autosomal dominant (with 43/85 mutations occurring de novo ); 78 were autosomal recessive; and 3 were X‐linked. We also identified 63 cases harbouring multiple pathogenic mutations, either involving two co‐existing genodermatoses (n = 13) or an inherited skin disorder in conjunction with other organ system phenotypes (n = 50). Conclusions NGS technologies have accelerated disease‐gene discoveries in dermatology over the last decade. Moreover, the era of NGS has enabled clinicians to split complex Mendelian phenotypes into separate diseases. These genetic data improve diagnostic precision and make feasible accurate prenatal testing and better‐targeted translational research.
17 May 2020 in Australasian Journal of Dermatology
29 March 2023 in British Journal of Dermatology
Genetic hair disorders, also known as genotrichoses, are characterized by abnormalities of hair structure, growth or differentiation, giving rise to a spectrum of phenotypes such as hypertrichosis, hypotrichosis and atrichia. These disorders may present as isolated phenotypes or be part of more complex phenotypes including abnormalities in skin or other organs. Genetic discoveries for hair disorders have been recently augmented with the advent of next-generation sequencing (NGS) technologies. We reviewed the literature and summarized disease–gene associations for inherited hair disorders, as well as genodermatoses presenting with hair abnormalities discovered by NGS technologies. We identified 28 nonsyndromic hair disorders, involving 25 individual genes and four unidentified genes. We have also discovered that approximately 30% of all the genodermatoses that were identified by NGS approaches demonstrated hair abnormalities as part of their phenotype. This review underscores the huge impact of NGS technologies in disclosing the genetics of hair disorders and the potential these discoveries provide for future translational research and new therapies.
25 February 2020 in Clinical and Experimental Dermatology
4 January 2020 in Clinical Infectious Diseases
We report two generalized verrucosis (GV) patients homozygous for a novel mutation in the start codon of IL7. Unlike the previous report in which IL-7 deficiency accompanied CD4 T lymphocytopenia, circulating CD4 T-cells were not depleted in one of our patients, suggesting a GV pathogenesis other than poor T-cell development.